Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P06889 (Mol)
 630,302 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Toxoplasma gondii, the intracellular parasite responsible for toxoplasmosis infects more than one-third of the world population and can be life-threatening for fetuses and immunocompromised patients. The surface protein SAG1 is an important immune target, which provides a strong immune response against the invasive tachyzoite while the other forms of the parasite, devoid of SAG1 at their surface, are multiplying. In addition to this role as a "hot spot" decoy, SAG1 is predicted to act as an adhesin during host-cell attachment through its binding to proteoglycans. To begin to understand the relationships between SAG1 epitopes and the ligand-binding site, we have solved the crystal structure of the monomeric form of T.gondii SAG1 complexed to a Fab derived from a monoclonal antibody raised against tachyzoite particles. This antibody competes strongly with human Toxoplasma-specific sera, suggesting that its epitope is part of an immunodominant region present on the surface of SAG1. The structure reveals that this conformational epitope, located within the SAG1 N-terminal domain, does not overlap with the proposed ligand-binding pocket. This study provides the first structural description of the monomeric form of SAG1, and significant insights into its dual role of adhesin and immune target during parasite infection.
J Mol Biol 2005 Nov 25
PMID:Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response. 1624 17

Cyclic GMP-dependent protein kinase (PKG) has been biochemically and genetically validated in Toxoplasma gondii as a primary target responsible for the antiparasitic activity of the trisubstituted pyrrole 4-[2-(4-fluorophenyl)-5-(1-methylpiperidine-4-yl)-1H pyrrol-3-yl] pyridine (Compound 1) [Biftu T, Feng D, Ponpipom M, et al. Synthesis and SAR of 2,3-diarylpyrrole inhibitors of parasite cGMP-dependent protein kinase as novel anticoccidial agents. Bioorg Med Chem Lett 2005;15:3296-301; Gurnett AM, Liberator PA, Dulski PM, et al. Purification and molecular characterization of cGMP-dependent protein kinase from Apicomplexan parasites. A novel chemotherapeutic target. J Biol Chem 2002;277:15913-22; Donald RGK, Allocco J, Singh SB, et al. Toxoplasma gondii cyclic GMP-dependent kinase: Chemotherapeutic targeting of an essential parasite protein kinase. Eukaryotic Cell 2002;1:317-28; Nare B, Allocco J, Liberator PA, Donald RGK. Evaluation of a cyclic GMP-dependent protein kinase inhibitor in treatment of murine Toxoplasmosis: Gamma interferon is required for efficacy. Antimicrob Agents Chemother 2002;46:300-7]. Compound 1 inhibits the growth of several related protozoan parasites of the subphylum Apicomplexa. Native PKG activity has been partially purified by cGMP-affinity and MonoQ ion exchange chromatography from Plasmodium falciparum (PfPKG). Biochemical fractions enriched for a 98kDa protein detected using anti-PKG antisera, contain cGMP-induced protein kinase activity that is sensitive to inhibition by Compound 1. To enable a more thorough characterization of PfPKG we expressed a synthetic cDNA incorporating T. gondii codon preference (Pf(Tg)PKG) in T. gondii parasites. The protein kinase activity of purified recombinant Pf(Tg)PKG is stimulated by cGMP, with significant cooperativity as demonstrated by a Hill coefficient of 2. Both substrate preference and inhibition of Pf(Tg)PKG kinase activity by Compound 1 are similar to that seen with native PfPKG, as well as PKG enzymes from Eimeria spp. and T. gondii. We conclude that PfPKG has biochemical and pharmacological properties that are similar to previously characterized apicomplexan PKG enzymes. Compound 1 is active against blood cell stages of P. falciparum cultured in vitro. In a Plasmodium berghei mouse model of infection, Compound 1 delays the onset of parasitemia but does not cure the parasite infection.
Mol Biochem Parasitol 2006 Mar
PMID:Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor. 1632 79

Protozoan parasites of the phylum Apicomplexa harbour a chloroplast-like organelle, the apicoplast. The biosynthetic pathways localized to this organelle are of cyanobacterial origin and therefore offer attractive targets for the development of new drugs for the treatment of malaria and toxoplasmosis. The apicoplast also provides a unique system to study the cell biology of endosymbiosis. This organelle is the product of secondary endosymbiosis, the marriage of an alga and an auxotrophic eukaryote. This origin has led to a fascinating set of novel cellular mechanisms that are clearly distinct from those employed by the plant chloroplast. Here we explore how the apicoplast interacts with its 'host' to secure building blocks for its biogenesis and how the organelle is divided and segregated during mitosis. Considerable advances in parasite genetics and genomics have transformed apicomplexans, long considered hard to study, into highly tractable model organisms. We discuss how these resources might be marshalled to develop a detailed mechanistic picture of apicoplast cell biology.
Mol Microbiol 2006 Sep
PMID:The cell biology of secondary endosymbiosis--how parasites build, divide and segregate the apicoplast. 1696 20

Many infectious diseases of global impact are caused by parasites. This includes diseases with protozoan etiology, such as malaria, African sleeping sickness, Chagas disease, toxoplasmosis, and amoebiasis, as well as diseases caused by metazoa, such as river blindness, schistosomiasis, ecchinococcosis, and ascariasis. Combined, parasitic diseases affect more than half the world's human population and are responsible for decreased gross national products and billions of dollars in lost earnings. Although the magnitude of the problem precludes quick solutions, there is reasonable hope that a better understanding of these organisms, especially the host-parasite interactions that underpin virulence and pathogenicity mechanisms, will provide new opportunities for rational intervention strategies. Yeast artificial chromosomes (YAC) have substantially aided in this endeavor by providing an unlimited access to defined parts of a parasite's genome, which, in turn, has facilitated a broad range of molecular studies. For example, YACs have facilitated positional cloning strategies to identify genes involved in antigenic variation and drug resistance mechanisms. Moreover, YACs have been invaluable tools for the many genome sequencing projects examining parasites. In this chapter, we provide a detailed protocol of how to generate representative YAC libraries from parasite genomes. This protocol can be applied to both protozoa and metazoa, and can even be used for YAC library construction of parasite material isolated from a single infected host.
Methods Mol Biol 2006
PMID:Construction of yeast artificial chromosome libraries from pathogens and nonmodel organisms. 1707 69

Parasites from the protozoan phylum Apicomplexa are responsible for diseases, such as malaria, toxoplasmosis and cryptosporidiosis, all of which have significantly higher rates of mortality and morbidity in economically underdeveloped regions of the world. Advances in vaccine development and drug discovery are urgently needed to control these diseases and can be facilitated by production of purified recombinant proteins from Apicomplexan genomes and determination of their 3D structures. To date, both heterologous expression and crystallization of Apicomplexan proteins have seen only limited success. In an effort to explore the effectiveness of producing and crystallizing proteins on a genome-scale using a standardized methodology, over 400 distinct Plasmodium falciparum target genes were chosen representing different cellular classes, along with select orthologues from four other Plasmodium species as well as Cryptosporidium parvum and Toxoplasma gondii. From a total of 1008 genes from the seven genomes, 304 (30.2%) produced purified soluble proteins and 97 (9.6%) crystallized, culminating in 36 crystal structures. These results demonstrate that, contrary to previous findings, a standardized platform using Escherichia coli can be effective for genome-scale production and crystallography of Apicomplexan proteins. Predictably, orthologous proteins from different Apicomplexan genomes behaved differently in expression, purification and crystallization, although the overall success rates of Plasmodium orthologues do not differ significantly. Their differences were effectively exploited to elevate the overall productivity to levels comparable to the most successful ongoing structural genomics projects: 229 of the 468 target genes produced purified soluble protein from one or more organisms, with 80 and 32 of the purified targets, respectively, leading to crystals and ultimately structures from one or more orthologues.
Mol Biochem Parasitol 2007 Jan
PMID:Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms. 1712 54

The apicomplexa are parasitic protozoa that are responsible for important human and animal diseases, including malaria, toxoplasmosis, cryptosporidiosis, coccidiosis and babesiosis. Like other members of the superphylum Alveolata, apicomplexans have regulated exocytosis of specialized secretory organelles, such as the apicomplexan-specific rhoptries and micronemes that are required for host cell invasion. The secretions of another class of organelles, the dense granules and osmiophilic bodies, are proposed to be required for maintenance of the parasitophorous vacuole and host cell egress. Little is known about the osmiophilic bodies and to date only one protein, P377, has been localized to this organelle. In this issue, de Koning-Ward et al. describe the disruption of pfg377 in the virulent human malaria parasite, Plasmodium falciparum, which results in reduced osmiophilic body formation, a marked decrease in female fitness, and dramatically impaired infectivity to mosquitoes. These findings suggest that targeting PFG377 may be a strategy to block parasite transmission.
Mol Microbiol 2008 Jan
PMID:Osmiophilic bodies and the odd organelles of alveolates. 1808 89

Alveolates are a recently recognized group of unicellular eukaryotes that unites disparate protists including apicomplexan parasites (which cause malaria and toxoplasmosis), dinoflagellate algae (which cause red tides and are symbionts in many corals), and ciliates (which are microscopic predators and common rumen symbionts). Gene sequence trees provide robust support for the alveolate alliance, but beyond the common presence of membranous sacs (alveoli) subtending the plasma membrane, the group has no unifying morphological feature. We describe a family of proteins, alveolins, associated with these membranous sacs in apicomplexa, dinoflagellates, and ciliates. Alveolins contain numerous simple peptide repeats and are encoded by multigene families. We generated antibodies against a peptide motif common to all alveolins and identified a range of apparently abundant proteins in apicomplexa, dinoflagellates, and ciliates. Immunolocalization reveals that alveolins are associated exclusively with the cortical regions of apicomplexa, dinoflagellates, and ciliates where the alveolar sacs occur. Alveolins are the first molecular nexus between the unifying structures that defines this eukaryotic group. They provide an excellent opportunity to explore the exceptional compartment that was apparently the key to a remarkable diversification of unique protists that occupy a wide array of lifestyle niches.
Mol Biol Evol 2008 Jun
PMID:Alveolins, a new family of cortical proteins that define the protist infrakingdom Alveolata. 1835 44

Although parasite-infected host cells become resistant to apoptosis, uninfected bystander cells undergo apoptosis during Toxoplasma gondii infection. The Programmed Cell Death 5 (TgPDCD5) gene, a homologue of the human apoptosis-related molecule, was cloned from a T. gondii full-length cDNA database and subsequently characterized. The native TgPDCD5 was located in the cytosol and also detected in the secreted fraction. Immuno-electron microscopic analysis showed TgPDCD5 was primarily located close to the rhoptries or vesicle-like structures near the surface membrane of the parasite. Studies using recombinant TgPDCD5 (rTgPDCD5) demonstrated that host cells internalize the molecule in a heparan sulfate proteoglycan-binding motif-dependent manner. Furthermore, the addition of rTgPDCD5 to culture medium resulted in the enhancement of host-cell apoptosis triggered by etoposide in macrophage cell line J774A.1 and leukemic cell line HL-60 cells. Additionally, rTgPDCD5 induced apoptosis in J774A.1 cells in the presence of IFN-gamma. This report is the first to identify a parasitic molecule of T. gondii that has a pro-apoptotic effect on host cells.
Mol Biochem Parasitol 2008 Jun
PMID:Programmed Cell Death 5 from Toxoplasma gondii: a secreted molecule that exerts a pro-apoptotic effect on host cells. 1840 78

Hammondia hammondi and Toxoplasma gondii are closely related protozoan parasites. Both species use felids as definitive hosts and a broad spectrum of warm-blooded animals as intermediate hosts. Morphologically and serologically, the two parasites are difficult to differentiate. While T. gondii is an important pathogen of humans and a broad range of other vertebrates, disease has not yet been associated with H. hammondi infection. The aim of the present study was to identify and characterize a repetitive DNA fragment in H. hammondi and to evaluate its suitability for diagnostic purposes. With two primers considered to be specific for a 529 bp repetitive DNA fragment in T. gondii, weak products were amplified by polymerase chain reaction (PCR) from genomic DNA from H. hammondi oocysts. These amplicons (of approximately 150, 300 and 450 bp) were sequenced. The 292 bp consensus sequence of these three fragments revealed 84% identity with parts of the 529-bp repeat in T. gondii. Based on this sequence, a pair of primers was selected which amplified products of 98 and 630 bp from genomic DNA from H. hammondi oocysts but not from DNA from T. gondii. The 630-bp product was purified and cloned into a plasmid vector and the consensus sequence determined from seven randomly selected clones; comparison of this sequence with those available in current databases for T. gondii revealed an 84.0-88.1% identity over a length of 529 bp. The sequence data obtained was used for the development of a sensitive PCR which is entirely specific for H. hammondi and incorporates an internal control. The sequence data for the repetitive DNA element of H. hammondi provides a foundation for the design of primers specific to T. gondii, and the future optimisation of conventional and real-time PCR assays for the specific diagnosis of toxoplasmosis in definitive and intermediate hosts.
Mol Cell Probes 2008 Aug
PMID:Characterization of a repetitive DNA fragment in Hammondia hammondi and its utility for the specific differentiation of H. hammondi from Toxoplasma gondii by PCR. 1855 66

Toxoplasma gondii is an obligatory intracellular parasitic protozoan that infects a variety of avian and mammalian hosts including up to one third of the human population worldwide. Developmental differentiation between distinct stages, i.e. sporozoites, tachyzoites and bradyzoites is fundamental for the parasite life cycle and for transmission between hosts. It is also interconnected with the pathogenesis of overt toxoplasmosis and makes T. gondii an important opportunistic pathogen of humans. In order to delineate the underlying mechanisms, several cell culture differentiation systems have been developed which mimic the transition from fast-replicating tachyzoites to slowly proliferating bradyzoites in vitro. Since exogenous stress factors, i.e. alkaline pH, IFN-gamma and other proinflammatory cytokines, chemicals or drugs, heat shock, and deprivation of nutrients have been shown to increase the efficacy of bradyzoite development in vitro, Toxoplasma stage differentiation is largely viewed as a stress-related response to hostile environmental conditions. However, tachyzoite to bradyzoite differentiation also occurs spontaneously in vitro and this raises questions about the importance of stress conditions for triggering stage conversion. High frequencies of spontaneous bradyzoite development in primary and permanent skeletal muscle cells, i.e. cells that preferentially harbour bradyzoite-containing tissue cysts in vivo suggest that the host cell type may be critical. Furthermore, the host cell transcriptome, including the expression of distinct host cell genes, has recently been shown to trigger bradyzoite development and cyst formation. Together, these results strongly indicate that the complex cellular environment, besides exogenous stress factors, may govern the developmental differentiation of T. gondii.
Mol Biosyst 2008 Aug
PMID:Stress-related and spontaneous stage differentiation of Toxoplasma gondii. 1863 84


<< Previous 1 2 3 4 5 6 7 8 9 Next >>